Overview

A Study of Baricitinib and Omeprazole in Healthy Participants

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to find out how the body will react to a study drug called baricitinib when taken with another drug called omeprazole. For each participant, this study will include 2 periods in fixed order. The study will last approximately 25 days, not including screening.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Omeprazole